Why it was recalled
Failed Impurities/Degradation Specification.
Product description
Rifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-575-21; NDC Unit Dose: 60687-575-11
Lot numbers, UPCs & expiration codes
Lot #: 1008111, Exp. Date 01/31/2024
Where it was sold
Nationwide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0285-2024
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Jan 11, 2024
- FDA report date
- Feb 7, 2024
- Quantity
- 1,568 cartons
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Amerisource Health Services LLC
Original FDA data
Every field from FDA enforcement report D-0285-2024, exactly as published.
Show all FDA fields
- City
- Columbus
- State
- OH
- Status
- Terminated
- Country
- United States
- Event ID
- 93851
- Address
- 2550 John Glenn Ave Ste A
- Code information
- Lot #: 1008111, Exp. Date 01/31/2024
- Postal code
- 43217-1188
- Report date
- Feb 7, 2024
- Product type
- Drugs
- Recall number
- D-0285-2024
- Classification
- Class II
- Recalling firm
- Amerisource Health Services LLC
- Product quantity
- 1,568 cartons
- Termination date
- Sep 30, 2024
- Reason for recall
- Failed Impurities/Degradation Specification.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Rifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-575-21; NDC Unit Dose: 60687-575-11
- Distribution pattern
- Nationwide in the USA
- Recall initiation date
- Jan 11, 2024
- Initial firm notification
- Letter
- Center classification date
- Jan 30, 2024